Chronic pelvic pain syndrome (CPPS) affects approximately 1 of 60 adults in the United States and is associated with significant disability and poor quality of life. Painful bladder syndrome/interstitial cystitis (PBS/IC) has emerged as a major cause of CPPS along with irritable bowel syndrome (IBS), endometriosis, and chronic prostatitis (CP). PBS/IC is a heterogeneous clinical syndrome occurring mostly in women, with some evidence suggesting it may have similar features to CP. PBS/IC is characterized by severe pelvic and perineal pain, as well as urgency and frequency of urination in the absence of a bacterial infection or bladder cancer. PBS/IC is associated with other comorbid conditions, such as allergies/asthma and fibromyalgia, that are worsened by stress. Neurogenic inflammation leading to neuropathic pain has been increasingly implicated in PBS/IC. There are no curative treatments. Management of PBS/IC should address younger, newly diagnosed patients. This could be accomplished with unique nutraceutical formulations containing
natural bladder lining rebuilding and antiinflammatory molecules, such as chondroitin sulfate, sodium hyaluronate, and quercetin.
Read Full Article (PDF)